Beta
Company data is growing.
← All companies
/
Top lists
/
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
1 702
2 489
3 048
4 163
6 206
7 574
8 931
9 869
11 020
12 001
Operating profit (EBIT)
10
123
635
1 198
2 856
2 782
4 307
3 832
−233
4 173
Net income attributable to shareholders
−112
263
2 097
1 177
2 712
2 342
3 322
3 620
−536
3 953
EBIT margin
0,6%
5,0%
20,8%
28,8%
46,0%
36,7%
48,2%
38,8%
−2,1%
34,8%
Gross margin
87,9%
89,0%
86,6%
86,8%
88,1%
88,1%
87,9%
87,2%
86,1%
86,2%
Operating cash flow
236
845
1 270
1 569
3 254
2 644
4 130
3 537
−493
3 631
Free cash flow
180
746
1 175
1 494
2 994
2 409
3 925
3 337
−790
3 194
Cash
1 184
1 665
2 650
3 109
5 988
6 795
10 504
10 369
4 570
5 085
−5 000
0
5 000
10 000
15 000
−20,0%
0,0%
20,0%
40,0%
60,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
1 702
2 489
3 048
4 163
6 206
7 574
8 931
9 869
11 020
12 001
10
123
635
1 198
2 856
2 782
4 307
3 832
−233
4 173